Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | %Female (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Advanced Therapeutics | journal | 39 | 53 | 0 | 5982 | 0 | 0 | 0.00 | 112.87 | 34.92 | ||
2 | Expert Opinion on Emerging Drugs | journal | 0.977 Q2 | 54 | 29 | 116 | 2879 | 361 | 108 | 3.05 | 99.28 | 32.58 | |
3 | Cochrane Database of Systematic Reviews | journal | 1.609 Q1 | 327 | 1109 | 4456 | 109105 | 17077 | 4430 | 3.51 | 98.38 | 48.02 | |
4 | Neurotherapeutics | journal | 2.565 Q1 | 136 | 92 | 252 | 8483 | 1460 | 233 | 5.29 | 92.21 | 40.44 | |
5 | Pharmacopsychiatry | journal | 0.667 Q2 | 84 | 39 | 133 | 3413 | 267 | 115 | 2.16 | 87.51 | 29.25 | |
6 | Expert Review of Neurotherapeutics | journal | 1.064 Q1 | 98 | 92 | 369 | 7652 | 1176 | 325 | 3.10 | 83.17 | 31.97 | |
7 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 13 | 6 | 4 | 488 | 10 | 3 | 2.50 | 81.33 | 56.25 | ||
8 | Expert Opinion on Investigational Drugs | journal | 1.076 Q1 | 117 | 94 | 395 | 7440 | 1303 | 376 | 3.61 | 79.15 | 37.26 | |
9 | Journal of Cardiovascular Development and Disease | journal | 32 | 63 | 73 | 4970 | 129 | 70 | 1.75 | 78.89 | 47.60 | ||
10 | Expert Review of Clinical Pharmacology | journal | 0.731 Q2 | 60 | 119 | 341 | 9352 | 901 | 316 | 2.53 | 78.59 | 35.77 | |
11 | Journal of Biomedical Science | journal | 1.611 Q1 | 110 | 90 | 283 | 6998 | 1398 | 283 | 5.40 | 77.76 | 42.55 | |
12 | Vaccines | journal | 2.136 Q1 | 85 | 81 | 150 | 6256 | 848 | 145 | 4.94 | 77.23 | 45.43 | |
13 | Expert Opinion on Orphan Drugs | journal | 0.302 Q3 | 27 | 77 | 350 | 5928 | 262 | 338 | 0.74 | 76.99 | 41.74 | |
14 | Expert Review of Anticancer Therapy | journal | 0.881 Q2 | 85 | 127 | 391 | 9577 | 886 | 353 | 2.39 | 75.41 | 35.84 | |
15 | Expert Opinion on Pharmacotherapy | journal | 0.866 Q2 | 93 | 213 | 696 | 15010 | 2012 | 652 | 2.80 | 70.47 | 34.87 | |
16 | Drugs | journal | 1.527 Q1 | 188 | 161 | 480 | 11332 | 2556 | 471 | 5.41 | 70.39 | 36.91 | |
17 | CNS Drugs | journal | 1.553 Q1 | 129 | 90 | 251 | 6083 | 1204 | 247 | 4.41 | 67.59 | 40.57 | |
18 | Side Effects of Drugs Annual | book series | 0.108 Q4 | 9 | 50 | 147 | 3307 | 77 | 3 | 0.65 | 66.14 | 0.00 | |
19 | Antibiotics | journal | 1.121 Q1 | 77 | 110 | 114 | 7149 | 397 | 111 | 3.18 | 64.99 | 48.57 | |
20 | Frontiers in Pharmacology | journal | 1.256 Q1 | 154 | 1497 | 1757 | 97013 | 7210 | 1686 | 3.87 | 64.80 | 44.28 | |
21 | Paediatric Drugs | journal | 0.620 Q2 | 70 | 54 | 152 | 3443 | 323 | 145 | 1.87 | 63.76 | 47.56 | |
22 | European Neuropsychopharmacology | journal | 1.911 Q1 | 130 | 124 | 551 | 7515 | 2478 | 529 | 4.34 | 60.60 | 41.37 | |
23 | BioDrugs | journal | 1.601 Q1 | 79 | 60 | 128 | 3632 | 663 | 124 | 5.11 | 60.53 | 36.27 | |
24 | Expert Opinion on Drug Safety | journal | 1.007 Q2 | 90 | 131 | 484 | 7888 | 1613 | 465 | 3.34 | 60.21 | 45.54 | |
25 | Anales de la Real Academia Nacional de Farmacia (discontinued) | journal | 0.159 Q3 | 10 | 22 | 136 | 1309 | 17 | 118 | 0.12 | 59.50 | 55.56 | |
26 | Journal of Psychopharmacology | journal | 1.672 Q1 | 135 | 138 | 426 | 8170 | 1978 | 401 | 4.03 | 59.20 | 41.74 | |
27 | Therapeutic Advances in Respiratory Disease | journal | 1.020 Q2 | 50 | 38 | 118 | 2248 | 373 | 113 | 3.34 | 59.16 | 45.35 | |
28 | Targeted Oncology | journal | 1.322 Q1 | 59 | 73 | 205 | 4317 | 728 | 200 | 3.74 | 59.14 | 42.36 | |
29 | Clinical Pharmacokinetics | journal | 1.529 Q1 | 184 | 119 | 340 | 6974 | 1545 | 311 | 4.47 | 58.61 | 35.37 | |
30 | International Journal of Neuropsychopharmacology | journal | 1.846 Q1 | 125 | 138 | 406 | 7958 | 1857 | 395 | 4.21 | 57.67 | 39.33 | |
31 | Drugs and Aging | journal | 1.128 Q1 | 109 | 94 | 273 | 5367 | 871 | 266 | 2.92 | 57.10 | 43.10 | |
32 | Acta Pharmacologica Sinica | journal | 1.224 Q1 | 117 | 189 | 460 | 10647 | 1838 | 454 | 3.81 | 56.33 | 41.59 | |
33 | PharmaNutrition | journal | 0.665 Q2 | 30 | 25 | 61 | 1397 | 168 | 60 | 3.33 | 55.88 | 43.79 | |
34 | CNS Neuroscience and Therapeutics | journal | 1.122 Q1 | 91 | 137 | 352 | 7603 | 1071 | 290 | 3.00 | 55.50 | 46.80 | |
35 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.123 Q1 | 47 | 67 | 110 | 3581 | 391 | 110 | 3.04 | 53.45 | 37.78 | |
36 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 25 | 48 | 1307 | 134 | 48 | 2.48 | 52.28 | 47.37 | ||
37 | npj Vaccines | journal | 2.527 Q1 | 47 | 51 | 50 | 2652 | 236 | 48 | 4.72 | 52.00 | 42.75 | |
38 | European Archives of Psychiatry and Clinical Neuroscience | journal | 1.226 Q1 | 111 | 89 | 259 | 4531 | 721 | 221 | 2.64 | 50.91 | 43.33 | |
39 | Inflammopharmacology | journal | 0.894 Q2 | 68 | 125 | 134 | 6184 | 474 | 131 | 3.39 | 49.47 | 44.17 | |
40 | Therapeutic Advances in Drug Safety | journal | 1.131 Q1 | 46 | 61 | 85 | 2938 | 247 | 59 | 2.76 | 48.16 | 44.35 | |
41 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.710 Q2 | 61 | 69 | 252 | 3294 | 416 | 238 | 1.71 | 47.74 | 36.59 | |
42 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.877 Q2 | 57 | 59 | 183 | 2788 | 424 | 176 | 2.33 | 47.25 | 37.04 | |
43 | Drug and Alcohol Dependence | journal | 1.821 Q1 | 187 | 454 | 1318 | 21179 | 5193 | 1306 | 3.59 | 46.65 | 50.60 | |
44 | American Journal of Cardiovascular Drugs | journal | 0.903 Q2 | 60 | 50 | 135 | 2327 | 308 | 127 | 2.40 | 46.54 | 29.70 | |
45 | Clinica e Investigacion en Arteriosclerosis | journal | 0.241 Q3 | 21 | 39 | 134 | 1796 | 121 | 129 | 0.98 | 46.05 | 41.31 | |
46 | Molecular Therapy - Oncolytics | journal | 1.753 Q1 | 42 | 29 | 94 | 1314 | 488 | 93 | 5.79 | 45.31 | 42.06 | |
47 | Giornale Italiano di Farmacia Clinica | journal | 0.102 Q4 | 8 | 18 | 69 | 793 | 2 | 56 | 0.04 | 44.06 | 65.08 | |
48 | Fundamental and Clinical Pharmacology | journal | 0.712 Q2 | 85 | 72 | 197 | 3009 | 464 | 196 | 2.20 | 41.79 | 49.07 | |
49 | Orphanet Journal of Rare Diseases | journal | 1.589 Q1 | 136 | 225 | 519 | 8994 | 2296 | 513 | 3.99 | 39.97 | 54.33 | |
50 | Trials | journal | 1.287 Q1 | 98 | 690 | 1785 | 27506 | 4060 | 1740 | 2.04 | 39.86 | 47.54 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®